Paulo Lizano, MD, PhD is an expert in Psychiatry at Beth Israel Deaconess Medical Center (United States). As of October 2026, ScienceLeadR ranks Paulo Lizano in the top 1% of experts worldwide for Psychotic Disorders and Schizophrenia Spectrum and Other Psychotic Disorders. Paulo Lizano has authored 139 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 849 (community average: 125). How the SLR is computed.

LeadR Profile

Paulo Lizano, MD, PhD Beth Israel Deaconess Medical Center United States
849 ScienceLeadR Reputation 849
Network Map

Psychiatry

Subspecialties: Neurology - Psychology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026

Source: PubMed

University of Rochester Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 139

Citations

Citations: 1 775 1st author: 21 Last author: 48 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Patient-derived stem cell models of brain endothelial-neuron interactions in early course psychosis.
PMID 42871576 — cells, tumor necrosis factor-alpha, blood, microscopy, electron, scanning transmission, neurons, brain, stem cells, psychotic disorders
Front Psychiatry20260
Retinal Biomarkers of Cognition in Schizophrenia: A Systematic Review and Meta-Analysis.
PMID 42841301 — biomarkers, schizophrenia, tomography, optical coherence, retinaldehyde, psychotic disorders, cognition, psychiatry
Harv Rev Psychiatry20260
Cerebral perfusion alterations are associated with clinical phenotypes and biotypes across the psychosis spectrum.
PMID 42779463 — gray matter, bipolar disorder, phenotype, psychotic disorders
Psychol Med20260
The eye as a canary in the coal mine: oculomics for psychiatry.
PMID 42754624 — coal, mental disorders, neurosciences, psychiatry
Mol Psychiatry20260
Further Evidence Is Needed to Support the Perceptual Theory of Schizophrenia.
PMID 42698855 — schizophrenia
Biol Psychiatry Glob Open Sci20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 3
Phase 2 1

By status:

Completed 3
Terminated 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map